Profile data is unavailable for this security.
About the company
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
- Revenue in SEK (TTM)209.00m
- Net income in SEK10.00bn
- Incorporated1992
- Employees12.00
- LocationBure Equity ABNybrogatan 6STOCKHOLM 114 34SwedenSWE
- Phone+46 86140020
- Fax+46 86140038
- Websitehttps://www.bure.se/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Treasure ASA | -214.25m | 387.04m | 5.66bn | 0.00 | 14.51 | 0.7636 | -- | -- | 1.91 | 1.91 | -1.05 | 36.23 | -0.0298 | -- | -- | -- | 5.38 | 10.76 | 5.38 | 10.76 | -- | -- | -- | 887.92 | -- | -- | 0.00 | 262.19 | -- | -- | -15.28 | -- | -- | 26.72 |
| Svolder AB | 895.30m | 876.20m | 5.69bn | 6.00 | 6.23 | 0.9192 | -- | 6.35 | 8.68 | 8.68 | 8.73 | 58.80 | 0.1585 | -- | 157.07 | 149,216,700.00 | 15.51 | 12.58 | 15.55 | 12.63 | 96.93 | 97.87 | 97.87 | 96.09 | -- | -- | 0.00 | 14.64 | 283.16 | 138.51 | 266.74 | -- | 0.00 | 25.90 |
| eQ Oyj | 813.86m | 343.86m | 6.09bn | 104.00 | 17.62 | 7.76 | 17.04 | 7.49 | 0.7206 | 0.7206 | 1.71 | 1.64 | 0.7207 | -- | 119.17 | 695,524.80 | 30.45 | 31.07 | 34.33 | 37.81 | 98.82 | 99.25 | 42.25 | 44.88 | -- | -- | 0.0587 | 102.65 | -8.67 | 9.36 | -13.21 | 12.11 | -25.33 | 8.18 |
| Creades publ AB | 2.17bn | 2.10bn | 6.42bn | 8.00 | 4.45 | 0.9489 | -- | 2.96 | 15.49 | 15.49 | 16.01 | 72.72 | 0.2396 | -- | 149.86 | 310,428,600.00 | 23.19 | 13.15 | 23.54 | 13.38 | -- | -- | 96.78 | 93.42 | -- | -- | 0.0011 | 12.58 | 112.11 | -16.86 | 114.13 | 1.03 | -- | 2.71 |
| MedCap AB (publ) | 1.79bn | 227.90m | 8.04bn | 534.00 | 35.54 | 6.74 | 23.63 | 4.49 | 15.28 | 15.28 | 119.92 | 80.58 | 1.02 | 3.58 | 6.30 | 3,758,614.00 | 13.10 | 9.01 | 16.16 | 12.00 | 46.63 | 46.77 | 12.80 | 9.84 | 1.83 | 43.34 | 0.2248 | 0.00 | 42.84 | 17.49 | 46.43 | 47.82 | 2.82 | -- |
| Ratos AB | 32.35bn | 958.00m | 10.56bn | 11.05k | 10.90 | 0.8419 | 2.46 | 0.3263 | 2.89 | 2.89 | 98.46 | 37.37 | 0.9202 | 9.24 | 5.90 | 2,926,814.00 | 5.08 | 3.39 | 7.58 | 5.11 | 43.26 | 40.22 | 5.52 | 4.06 | 0.7346 | 1.32 | 0.3988 | 44.71 | 12.96 | 7.85 | 122.26 | -- | -15.01 | 20.11 |
| Kinnevik AB | 491.00m | -7.04bn | 20.78bn | 46.00 | -- | 0.5677 | -- | 42.33 | -25.01 | -25.01 | 1.74 | 132.01 | 0.01 | -- | -- | 10,673,910.00 | -14.32 | 13.28 | -15.03 | 13.51 | -- | -- | -1,434.42 | 486.46 | -- | 0.0103 | 0.0869 | -- | -73.54 | -13.08 | 75.58 | -- | -- | -- |
| Bure Equity AB | 209.00m | 10.00bn | 26.44bn | 12.00 | 2.65 | 1.02 | 2.64 | 126.51 | 134.52 | 134.52 | 2.81 | 350.20 | 0.0099 | -- | 418.00 | 20,900,000.00 | 47.39 | 11.10 | 47.48 | 11.14 | 83.25 | 78.76 | 4,784.21 | 800.92 | -- | -- | 0.0002 | 8.96 | -6.91 | -13.43 | 151.34 | 21.12 | -- | 4.56 |
| Avanza Bank Holding AB | 5.31bn | 2.13bn | 34.17bn | 691.00 | 16.06 | 5.99 | 15.38 | 6.44 | 13.53 | 13.53 | 33.72 | 36.25 | 0.0176 | -- | -- | 8,025,719.00 | 0.7064 | 0.6902 | 0.8982 | 0.8851 | 70.14 | 81.72 | 40.15 | 46.06 | -- | -- | 0.9219 | 65.53 | 36.60 | 28.34 | 18.97 | 41.53 | -0.8131 | 40.51 |
| Storebrand ASA | -16.69bn | 5.08bn | 55.00bn | 2.25k | 10.72 | 1.75 | 9.93 | -- | 11.47 | 11.47 | -37.64 | 70.31 | -0.0179 | -- | -- | -7,435,692.00 | 0.5493 | 0.3656 | -- | -- | -- | -- | -- | 4.19 | -- | -- | 0.6293 | 50.71 | -101.59 | -- | 41.83 | -1.88 | 29.40 | 6.45 |
| L E Lundbergforetagen AB (publ) | 28.95bn | 7.33bn | 79.12bn | 4.20k | 17.61 | 1.17 | 7.74 | 2.73 | 29.55 | 29.55 | 116.30 | 443.82 | 0.1357 | -- | 636.35 | 6,887,250.00 | 4.12 | 5.61 | 5.91 | 8.03 | -- | 57.41 | 30.34 | 42.68 | 0.8896 | -- | 0.1121 | 13.18 | -1.81 | 7.23 | 379.19 | 15.11 | 6.69 | 6.09 |
| Holder | Shares | % Held |
|---|---|---|
| AMF Fonder ABas of 31 Dec 2023 | 7.35m | 9.92% |
| Fj�rde AP-fondenas of 30 Jun 2024 | 5.67m | 7.65% |
| SEB Investment Management ABas of 31 Oct 2024 | 4.33m | 5.83% |
| F�rsta AP-fondenas of 30 Jun 2024 | 2.64m | 3.56% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 1.95m | 2.64% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 1.29m | 1.75% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 1.23m | 1.66% |
| Handelsbanken Fonder ABas of 31 Oct 2024 | 861.96k | 1.16% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 678.25k | 0.92% |
| American Century Investment Management, Inc.as of 07 Nov 2024 | 507.21k | 0.68% |
